2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
With equities kicking off 2023 on an upbeat note, there is real hope in the investing community that the stock market will remain northbound for the rest of the year. It's hard to know whether it will, but it may be a bit easier to predict the probable trajectory of some individual corporations.
Consider the case of CRISPR Therapeutics (NASDAQ: CRSP) and Fiverr (NYSE: FVRR), two stocks that have soared this year along with the broader market. These companies have important developments that could help them perform well through 2023. And more importantly, both look like solid stocks to buy even beyond this year. Let's dig in.
CRISPR Therapeutics is a gene editing-focused biotech. The company's shares are up by 36% this year, an impressive performance compared to the broader market. Perhaps CRISPR Therapeutics' run of form in 2023 has to do with the fact that it is inching closer to being a commercial-stage biotech.
Source Fool.com
